Fig. 2From: The role of CYP3A5 polymorphism and dose adjustments following conversion of twice-daily to once-daily tacrolimus in renal transplant recipientsTacrolimus dosing (mg/day) pre-conversion (Tac-BID) by genotypeBack to article page